Medical University Of Lausitz Carl Thiem — Clinical Trial Site

9 Registered trials

7 Currently recruiting

Organisation

Medical University Of Lausitz Carl Thiem

Location

Cottbus, Germany

Identifier

ORG-100053341

Address

Thiemstrasse 111, Spremberger Vorstadt, 03048, Germany

Departments

105: Klinik fuer Kinder- und Jugendmedizin
2.Medizinische Klinik für Hämatologie, Onkologie, Nephrologie, Diabetologie und Pneumologie
2.Medizinischen Klinik für Hämatologie, Onkologie , Nephrologie, Diabetologie & Pneumonologie
7105 :Abteilung fuer Neurologie
Brustzentrum
Frauenklinik
NA
Paediatrics Hematology/Oncology

Clinical trials at this site (9)

Search interface

NeoAdjuvant Dynamic marker - Adjusted Personalized Therapy comparing sacituzumab govitecan+pembrolizumab vs. SoC chemotherapy in clinical st… Pending

2024-516734-35-00 triple-negative early breast cancer 5
Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing adjuvant Elacestrant with standard endocrine treatment in genomically and/… Recruiting

2025-522484-15-00 ER+/HER2- early breast cancer 5 2026-04-27
Studies testing Ziftomenib together with standard treatments in adults with newly diagnosed acute myeloid leukemia (AML) that has specific g… Recruiting

2025-521314-25-00 NPM1-m and KMT2A-r Acute Myeloid Leukemia 5 2026-03-19
NoLEEta - Phase III non-inferiority trial of chemotherapy de-escalation in hormone receptorpositive, Her2-negative, intermediate-risk early … Recruiting

2025-520979-13-00 Patients with HR+ HER2- early breast cancer at intermed 5 2025-12-18
A Study to Assess the Adverse Events, Effectiveness, and How the Drug Moves through the Body of Intravenous and Subcutaneous Injections of R… Recruiting

2024-514695-41-00 Ulcerative Colitis 5 2025-10-17
A clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosi… Recruiting

2025-521546-23-00 Secondary progressive multiple sclerosis 5 2026-04-21
A study to extend treatment with JR-141 after completion of Study JR-141-GS31 Recruiting

2022-503142-41-00 Mucopolysaccharidosis type II 5 2024-05-06
Iberdomide Manteinance Versus Lenalidomide Manteinance Therapy Following Autologous Stem Cell Transplant in Participants with NDMM Recruiting

2022-501515-14-00 Newly Diagnosed Multiple Myeloma (NDMM) 5 2023-09-29
Phase III Clinical Trial for CPX-351 in Myeloid Leukemia in Children with Down Syndrome 2018 Ended

2022-501457-37-00 Myeloid Leukemia in Children with Down Syndrome 5 2024-10-28